The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Garassino, Marina Chiara
Item TypeName
Concept Proto-Oncogene Proteins
Concept Proto-Oncogene Proteins B-raf
Concept Proto-Oncogene Proteins p21(ras)
Concept Proto-Oncogene Proteins c-met
Academic Article Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Academic Article Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC.
Academic Article Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Academic Article Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.
Academic Article Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach.
Academic Article Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.
Academic Article Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Academic Article KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy.
Academic Article ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
Academic Article BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.
Academic Article Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?
Academic Article Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.
Academic Article Testing epidermal growth factor receptor mutations in patients with non-small-cell lung cancer to choose chemotherapy: the other side of the coin.
Academic Article G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.
Academic Article Targeting the MET gene for the treatment of non-small-cell lung cancer.
Academic Article Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
Academic Article Recurrent thrombosis followed by Lazarus response in ROS1 rearranged NSCLC treated with crizotinib: a case report.
Academic Article Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number.
Academic Article Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches.
Academic Article On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma.
Academic Article Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Academic Article Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
Search Criteria
  • Proto Oncogenes